Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Julie Sawyer Montgomery
CEOJulie Sawyer Montgomery
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
163.94B
Market cap163.94B
Price-Earnings ratio
38.15
Price-Earnings ratio38.15
Dividend yield
0.65%
Dividend yield0.65%
Average volume
3.41M
Average volume3.41M
High today
$233.76
High today$233.76
Low today
$229.92
Low today$229.92
Open price
$232.77
Open price$232.77
Volume
3.33M
Volume3.33M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$160.93
52 Week low$160.93

Stock Snapshot

Danaher(DHR) stock is priced at $233.02, giving the company a market capitalization of 163.94B. It carries a P/E multiple of 38.15 and pays a dividend yield of 0.65%.

During the trading session on 2026-11-16, Danaher(DHR) shares reached a daily high of $233.76 and a low of $229.92. At a current price of $233.02, the stock is +1.4% higher than the low and still -0.3% under the high.

Trading volume for Danaher(DHR) stock has reached 3.33M, versus its average volume of 3.41M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $160.93.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $160.93.

DHR News

TipRanks 1d
Danaher Earnings Call Signals Stronger Growth and Profitability - TipRanks

...

Danaher Earnings Call Signals Stronger Growth and Profitability - TipRanks
Simply Wall St 4d
Does Danaher Have More Upside After Its FDA Clearances?

has delivered solid multiyear gains for shareholders, and recent headlines around its life sciences and diagnostics units keep attention on the story. The open...

Does Danaher Have More Upside After Its FDA Clearances?
Zacks 6d
VTRS or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS Quick QuoteVTRS - Free Report) and Danaher (DHR Quick QuoteDHR -...

VTRS or DHR: Which Is the Better Value Stock Right Now?

Analyst ratings

81%

of 27 ratings
Buy
81.5%
Hold
18.5%
Sell
0%

More DHR News

Simply Wall St 6d
Should Single Use Bioreactors Require Action From Danaher Investors?

Danaher recently presented at the 2026 UBS Global Healthcare Conference, where CEO Julie Sawyer Montgomery outlined the group’s priorities in bioprocessing, lif...

Should Single Use Bioreactors Require Action From Danaher Investors?

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.